Abstract
The advent of post genomic technologies and their application to biomedical problems resulted in a massive increase the complexity of data generated. This has resulted in the need for more refined statistical and computational methods for analysis of this type of data Through comprehensive analysis and modelling approaches, structures or classes in the data can be defined, denovo predictive biomarkers identified and clinical decision support systems developed. This review seeks to provide an overview of some of the computational methodologies that have been used for data-mining complex high throughput data for the identification of new biomarkers or improvement of existing biomarkers. Given the literature is vast within the area of computational algorithms we seek to present commonly used methods.
Keywords: Biomarkers, ANN, SVM, logistic regression
Current Cancer Therapy Reviews
Title: Computational & Statistical Methodologies to Identify Biomarkers in Cancer
Volume: 4 Issue: 2
Author(s): Graham R. Ball
Affiliation:
Keywords: Biomarkers, ANN, SVM, logistic regression
Abstract: The advent of post genomic technologies and their application to biomedical problems resulted in a massive increase the complexity of data generated. This has resulted in the need for more refined statistical and computational methods for analysis of this type of data Through comprehensive analysis and modelling approaches, structures or classes in the data can be defined, denovo predictive biomarkers identified and clinical decision support systems developed. This review seeks to provide an overview of some of the computational methodologies that have been used for data-mining complex high throughput data for the identification of new biomarkers or improvement of existing biomarkers. Given the literature is vast within the area of computational algorithms we seek to present commonly used methods.
Export Options
About this article
Cite this article as:
Ball R. Graham, Computational & Statistical Methodologies to Identify Biomarkers in Cancer, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310043
DOI https://dx.doi.org/10.2174/157339408784310043 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases
Current Protein & Peptide Science Chitosan Surface-Modified PLGA Nanoparticles: Preparation, Characterization, and Evaluation of their In Vitro Drug-Release Behaviors and Cytotoxicities
Current Nanoscience The Significance of Ubiquitin Proteasome Pathway in Cancer Development
Recent Patents on Anti-Cancer Drug Discovery Graphical Abstracts:
Current Radiopharmaceuticals New Prospects for Nelfinavir in Non-HIV-Related Diseases
Current Molecular Pharmacology Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection
Current Pharmaceutical Design Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
Current Medicinal Chemistry Genetic Polymorphisms of Drug Metabolizing Enzymes and Transporters: The Long Way from Bench to Bedside
Current Topics in Medicinal Chemistry Impact of Viscosity and Refractive Index on Droplet Size and Zeta Potential of Model O/W and W/O Nanoemulsion
Current Nanoscience KCa3.1 Channels and Glioblastoma: In Vitro Studies
Current Neuropharmacology Editorial (Thematic Issues: New Developments in the Medicinal Chemistry of Some Azoles)
Current Topics in Medicinal Chemistry PIM1 Kinase as a Target in Prostate Cancer: Roles in Tumorigenesis, Castration Resistance, and Docetaxel Resistance
Current Cancer Drug Targets Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
Current Cancer Drug Targets New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
Current Topics in Medicinal Chemistry Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Current Pharmaceutical Biotechnology Dysregulated Post-Transcriptional Control of COX-2 Gene Expression in Cancer
Current Pharmaceutical Design Nanotechnology and Animal Health
Pharmaceutical Nanotechnology Use of Transgenic Mice as Models for Prostate Cancer Chemoprevention
Current Molecular Medicine Peptidyl Prolyl Isomerase, Pin1 is a Potential Target for Enhancing the Therapeutic Efficacy of Etoposide
Current Cancer Drug Targets Dendrimers Effects on the Immune System: Insights into Toxicity and Therapeutic Utility
Current Pharmaceutical Design